Observing Defect Passivation of the Grain Boundary with 2-Aminoterephthalic Acid for Efficient and Stable Perovskite Solar Cells.

Metal halide perovskite solar cells (PSCs), with their exceptional properties, show promise as photoelectric converters. However, defects in the perovskite layer, particularly at the grain boundaries (GBs), seriously restrict the performance and stability of PSCs. Now, a simple post-treatment procedure involves applying 2-aminoterephthalic acid to the perovskite to produce efficient and stable PSCs. By optimizing the post-treatment conditions, we created a device that achieved a remarkable power conversion efficiency (PCE) of 21.09 % and demonstrated improved stability. This improvement was attributed to the fact that the 2-aminoterephthalic acid acted as a cross-linking agent that inhibited the migration of ions and passivated the trap states at GBs. These findings provide a potential strategy for designing efficient and stable PSCs regarding the aspects of defect passivation and crystal growth.

Coagulated SnO2 Colloids for High-Performance Planar Perovskite Solar Cells with Negligible Hysteresis and Improved Stability.

Organic-inorganic perovskite solar cells with a planar architecture have attracted much attention due to the simple structure and easy fabrication. However, the power conversion efficiency and hysteresis behavior need to be improved for planar-type devices where the electron transport layer is vital. SnO2 is a promising alternative for TiO2 as the electron transport layer owing to the high charge mobility and chemical stability, but the hysteresis issue can still remain despite the use of SnO2 . Now, a facile and effective method is presented to simultaneously tune the electronic property of SnO2 and passivate the defects at the interface between the perovskite and SnO2 . The perovskite solar cells with ammonium chloride induced coagulated SnO2 colloids exhibit a power conversion efficiency of 21.38 % with negligible hysteresis, compared to 18.71 % with obvious hysteresis for the reference device. The device stability can also be significantly improved.

Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway.

Intestinal ischemia/reperfusion (I/R) induces disruption of the intestinal barrier function. Aryl hydrocarbon receptor (AhR) has a vital role in maintaining the intestinal barrier function. However, the precise mechanism by which AhR maintains intestinal barrier function remains unclear. Notch1 signaling is downstream of AhR, and has also been reported to have a role in the development of tight junctions (TJs) and maintenance of intestinal homeostasis. Therefore, we hypothesized that AhR activation may attenuate the intestinal barrier dysfunction through increased activation of Notch1 signaling. Adult C57BL/6J mice were divided into three groups: Sham, I/R and I/R + 6-formylindolo(3,2-b)carbazole (Ficz) groups. Mice were sacrificed after I/R for 6 h and the intestine was harvested for histological examination, mRNA and protein content analysis, and mucosal permeability investigation. Additionally, a hypoxic Caco­2 cell culture model was used to evaluate the role of AhR­Notch1 signaling in the development of TJs and epithelial permeability in vitro. The AhR­Notch1 signaling components and TJ proteins were assessed by reverse transcription­quantitative polymerase chain reaction, western blotting, immunohistochemistry or immunofluorescence staining. Epithelial permeability was detected by transepithelium electrical resistance. The data demonstrated that Ficz significantly attenuated the intestinal tissue damage and the disrupted distribution of TJs, increased the expression of TJ proteins, reversed the decrease in TER and upregulated epithelial Notch1 signaling following intestinal I/R in vivo and hypoxia in vitro. Furthermore, inhibition of Notch1 signaling by N­[N­(3,5­difluorophenacetyl)­L­alanyl]­S­phenylglycine t­butyl ester (inhibitor of Notch signaling) counteracted the effects of Ficz on the development of TJs in hypoxic Caco­2 cells. In conclusion, AhR activation ameliorated epithelial barrier dysfunction following intestinal I/R and hypoxia through upregulation of Notch1 signaling, which suggests that AhR may be a potential pharmaceutical agent to combat this condition.

Aryl hydrocarbon receptor activation modulates CD8αα+TCRαß+ IELs and suppression of colitis manifestations in mice.

BACKGROUND: This research is dedicated to investigating the effects and potential mechanism of action of the aryl hydrocarbon receptor on the intestinal mucosal immune system in dextran sulfate sodium (DSS)-induced colitis. METHODS: Colitis was induced by the administration of 3% DSS to wild-type C57BL/6J mice for 7days. 6-formylindolo(3, 2-b)carbazole (FICZ), an endogenous agonist of the aryl hydrocarbon receptor (AhR), was given intraperitoneally on a daily basis beginning 2days after the start of DSS administration. The mice were weighed and assessed, and colon tissues were measured. Intraepithelial lymphocytes (IELs) were isolated from the colon and examined by flow cytometry and quantitative real-time PCR. RESULTS: FICZ ameliorated DSS-induced colitis, resulting in a reduced disease activity index and improvement in the histology and length of the colon. Colitis reduced the percentage and number of CD8αα+TCRαß+ IELs. FICZ prevented the reduction in the numbers of CD8αα+TCRαß+ IELs by upregulating the expression of the IL-15 receptor and the aryl hydrocarbon receptor (AhR), and attenuating the apoptotic rate of CD8αα+TCRαß+ IELs. Finally, IL-10 was increased and IFN-γ was decreased in CD8αα+TCRαß+ IELs by FICZ administration in DSS-induced colitis. CONCLUSIONS: The results suggest that AhR activation ameliorated DSS-induced acute colitis, in a manner that is associated with the local expansion and functions of CD8αα+TCRαß+ IELs in acute colitis. The findings indicate that AhR-related ligands might be targeted as novel drug targets for IBD.